# Warby Parker Inc.: financial statements, quarterly

WRBY · NYSE · CIK 1504776 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wrby.md) · [Financials](/companies/wrby/financials.md) · [Filings](/companies/wrby/filings.md) · [Insiders](/companies/wrby/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wrby/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [170](/filings/0001504776-24-000026.md) | [162 d](/filings/0001504776-26-000006.md) | [200](/filings/0001504776-25-000019.md) | [188](/filings/0001504776-25-000027.md) | [192](/filings/0001504776-25-000033.md) | [191 d](/filings/0001504776-26-000006.md) | [224](/filings/0001504776-26-000011.md) | [214](/filings/0001504776-26-000019.md) | [222](/filings/0001504776-25-000033.md) | [212 d](/filings/0001504776-26-000006.md) | [242](/filings/0001504776-26-000011.md) | [236](/filings/0001504776-26-000019.md) |
| Cost of revenue | $m | [77.1](/filings/0001504776-24-000026.md) | [74.8 d](/filings/0001504776-26-000006.md) | [86.5](/filings/0001504776-25-000019.md) | [82.8](/filings/0001504776-25-000027.md) | [87.6](/filings/0001504776-25-000033.md) | [87.5 d](/filings/0001504776-26-000006.md) | [97.8](/filings/0001504776-26-000011.md) | [101](/filings/0001504776-26-000019.md) | [102](/filings/0001504776-25-000033.md) | [101 d](/filings/0001504776-26-000006.md) | [111](/filings/0001504776-26-000011.md) | [99.1](/filings/0001504776-26-000019.md) |
| Gross profit | $m | [92.7](/filings/0001504776-24-000026.md) | [87.1 d](/filings/0001504776-26-000006.md) | [113](/filings/0001504776-25-000019.md) | [105](/filings/0001504776-25-000027.md) | [105](/filings/0001504776-25-000033.md) | [103 d](/filings/0001504776-26-000006.md) | [126](/filings/0001504776-26-000011.md) | [114](/filings/0001504776-26-000019.md) | [120](/filings/0001504776-25-000033.md) | [111 d](/filings/0001504776-26-000006.md) | [131](/filings/0001504776-26-000011.md) | [136](/filings/0001504776-26-000019.md) |
| Selling, general and administrative | $m | [112](/filings/0001504776-24-000026.md) | [109 d](/filings/0001504776-26-000006.md) | [119](/filings/0001504776-25-000019.md) | [114](/filings/0001504776-25-000027.md) | [111](/filings/0001504776-25-000033.md) | [113 d](/filings/0001504776-26-000006.md) | [124](/filings/0001504776-26-000011.md) | [118](/filings/0001504776-26-000019.md) | [116](/filings/0001504776-25-000033.md) | [118 d](/filings/0001504776-26-000006.md) | [129](/filings/0001504776-26-000011.md) | [133](/filings/0001504776-26-000019.md) |
| Operating income | $m | [(19.8)](/filings/0001504776-24-000026.md) | [(21.6) d](/filings/0001504776-26-000006.md) | [(5.1)](/filings/0001504776-25-000019.md) | [(9.0)](/filings/0001504776-25-000027.md) | [(6.6)](/filings/0001504776-25-000033.md) | [(9.4) d](/filings/0001504776-26-000006.md) | [2.5](/filings/0001504776-26-000011.md) | [(4.5)](/filings/0001504776-26-000019.md) | [3.6](/filings/0001504776-25-000033.md) | [(6.9) d](/filings/0001504776-26-000006.md) | [1.7](/filings/0001504776-26-000011.md) | [3.2](/filings/0001504776-26-000019.md) |
| Income tax | $m | [0.3](/filings/0001504776-24-000026.md) | [(0.1) d](/filings/0001504776-26-000006.md) | [0.1](/filings/0001504776-25-000019.md) | [0.4](/filings/0001504776-25-000027.md) | [0.3](/filings/0001504776-25-000033.md) | [0.1 d](/filings/0001504776-26-000006.md) | [1.5](/filings/0001504776-26-000011.md) | [(0.8)](/filings/0001504776-26-000019.md) | [(0.1)](/filings/0001504776-25-000033.md) | [0.9 d](/filings/0001504776-26-000006.md) | [0.8](/filings/0001504776-26-000011.md) | [0.6](/filings/0001504776-26-000019.md) |
| Net income | $m | [(17.4)](/filings/0001504776-24-000026.md) | [(19.0) d](/filings/0001504776-26-000006.md) | [(2.7)](/filings/0001504776-25-000033.md) | [(6.8)](/filings/0001504776-25-000033.md) | [(4.1)](/filings/0001504776-25-000033.md) | [(6.9) d](/filings/0001504776-26-000006.md) | [3.5](/filings/0001504776-26-000019.md) | [(1.8)](/filings/0001504776-26-000019.md) | [5.9](/filings/0001504776-25-000033.md) | [(6.0) d](/filings/0001504776-26-000006.md) | [3.2](/filings/0001504776-26-000019.md) | [4.6](/filings/0001504776-26-000019.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001504776-24-000026.md) | not reported | [(0.02)](/filings/0001504776-25-000019.md) | [(0.06)](/filings/0001504776-25-000027.md) | [(0.03)](/filings/0001504776-25-000033.md) | not reported | [0.03](/filings/0001504776-26-000011.md) | [(0.01)](/filings/0001504776-26-000019.md) | [0.05](/filings/0001504776-25-000033.md) | not reported | [0.03](/filings/0001504776-26-000011.md) | [0.04](/filings/0001504776-26-000019.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001504776-24-000026.md) | not reported | [(0.02)](/filings/0001504776-25-000019.md) | [(0.06)](/filings/0001504776-25-000027.md) | [(0.03)](/filings/0001504776-25-000033.md) | not reported | [0.03](/filings/0001504776-26-000011.md) | [(0.01)](/filings/0001504776-26-000019.md) | [0.05](/filings/0001504776-25-000033.md) | not reported | [0.03](/filings/0001504776-26-000011.md) | [0.04](/filings/0001504776-26-000019.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [216](/filings/0001504776-23-000025.md) | [217](/filings/0001504776-25-000010.md) | [220](/filings/0001504776-24-000012.md) | [238](/filings/0001504776-24-000019.md) | [251](/filings/0001504776-24-000026.md) | [254](/filings/0001504776-26-000006.md) | [265](/filings/0001504776-25-000019.md) | [286](/filings/0001504776-25-000027.md) | [280](/filings/0001504776-25-000033.md) | [286](/filings/0001504776-26-000019.md) | [288](/filings/0001504776-26-000011.md) | [293](/filings/0001504776-26-000019.md) |
| Current assets | $m | [295](/filings/0001504776-23-000025.md) | [299](/filings/0001504776-25-000010.md) | [296](/filings/0001504776-24-000012.md) | [309](/filings/0001504776-24-000019.md) | [321](/filings/0001504776-24-000026.md) | [326](/filings/0001504776-26-000006.md) | [331](/filings/0001504776-25-000019.md) | [346](/filings/0001504776-25-000027.md) | [344](/filings/0001504776-25-000033.md) | [352](/filings/0001504776-26-000019.md) | [358](/filings/0001504776-26-000011.md) | [371](/filings/0001504776-26-000019.md) |
| Total assets | $m | [575](/filings/0001504776-23-000025.md) | [580](/filings/0001504776-25-000010.md) | [593](/filings/0001504776-24-000012.md) | [618](/filings/0001504776-24-000019.md) | [638](/filings/0001504776-24-000026.md) | [676](/filings/0001504776-26-000006.md) | [683](/filings/0001504776-25-000019.md) | [702](/filings/0001504776-25-000027.md) | [707](/filings/0001504776-25-000033.md) | [721](/filings/0001504776-26-000019.md) | [736](/filings/0001504776-26-000011.md) | [772](/filings/0001504776-26-000019.md) |
| Current liabilities | $m | [122](/filings/0001504776-23-000025.md) | [127](/filings/0001504776-25-000010.md) | [119](/filings/0001504776-24-000012.md) | [121](/filings/0001504776-24-000019.md) | [130](/filings/0001504776-24-000026.md) | [130](/filings/0001504776-26-000006.md) | [123](/filings/0001504776-25-000019.md) | [136](/filings/0001504776-25-000027.md) | [132](/filings/0001504776-25-000033.md) | [150](/filings/0001504776-26-000019.md) | [153](/filings/0001504776-26-000011.md) | [163](/filings/0001504776-26-000019.md) |
| Total liabilities | $m | [270](/filings/0001504776-23-000025.md) | [279](/filings/0001504776-25-000010.md) | [277](/filings/0001504776-24-000012.md) | [289](/filings/0001504776-24-000019.md) | [301](/filings/0001504776-24-000026.md) | [336](/filings/0001504776-26-000006.md) | [329](/filings/0001504776-25-000019.md) | [340](/filings/0001504776-25-000027.md) | [337](/filings/0001504776-25-000033.md) | [353](/filings/0001504776-26-000019.md) | [361](/filings/0001504776-26-000011.md) | [380](/filings/0001504776-26-000019.md) |
| Shareholders' equity | $m | [305](/filings/0001504776-24-000026.md) | [302](/filings/0001504776-26-000006.md) | [316](/filings/0001504776-25-000033.md) | [329](/filings/0001504776-25-000033.md) | [337](/filings/0001504776-25-000033.md) | [340](/filings/0001504776-26-000019.md) | [354](/filings/0001504776-26-000019.md) | [361](/filings/0001504776-26-000019.md) | [370](/filings/0001504776-25-000033.md) | [368](/filings/0001504776-26-000019.md) | [376](/filings/0001504776-26-000019.md) | [392](/filings/0001504776-26-000019.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [19.9 d](/filings/0001504776-24-000026.md) | [13.7 d](/filings/0001504776-26-000006.md) | [19.9](/filings/0001504776-25-000019.md) | [31.6 d](/filings/0001504776-25-000027.md) | [27.3 d](/filings/0001504776-25-000033.md) | [19.9 d](/filings/0001504776-26-000006.md) | [29.4](/filings/0001504776-26-000011.md) | [40.2 d](/filings/0001504776-26-000019.md) | [18.0 d](/filings/0001504776-25-000033.md) | [23.3 d](/filings/0001504776-26-000006.md) | [24.5](/filings/0001504776-26-000011.md) | [29.6 d](/filings/0001504776-26-000019.md) |
| Capital expenditure | $m | [15.5 d](/filings/0001504776-24-000026.md) | [13.6 d](/filings/0001504776-26-000006.md) | [14.4](/filings/0001504776-25-000019.md) | [17.7 d](/filings/0001504776-25-000027.md) | [14.2 d](/filings/0001504776-25-000033.md) | [17.7 d](/filings/0001504776-26-000006.md) | [16.2](/filings/0001504776-26-000011.md) | [16.3 d](/filings/0001504776-26-000019.md) | [19.5 d](/filings/0001504776-25-000033.md) | [15.1 d](/filings/0001504776-26-000006.md) | [16.1](/filings/0001504776-26-000011.md) | [22.9 d](/filings/0001504776-26-000019.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [115](/filings/0001504776-23-000025.md) | [116](/filings/0001504776-24-000012.md) | [117](/filings/0001504776-24-000019.md) | [118](/filings/0001504776-24-000026.md) | [119](/filings/0001504776-25-000019.md) | [120](/filings/0001504776-25-000027.md) | [121](/filings/0001504776-25-000033.md) | [125](/filings/0001504776-26-000011.md) | [123](/filings/0001504776-26-000019.md) | [125](/filings/0001504776-25-000033.md) | [126](/filings/0001504776-26-000011.md) | [126](/filings/0001504776-26-000019.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 113,182,975 at 2021-11-09, from the cover of the [10-Q filed 2021-11-12](/filings/0001628280-21-023046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.